Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial
- Auteur
- SANDBORN, William J1 ; HANAUER, Stephen B2 ; KATZ, Seymour3 ; SAFDI, Michael4 ; WOLF, Douglas G5 ; BAERG, Richard D6 ; TREMAINE, William J1 ; JOHNSON, Therese1 ; DIEHL, Nancy N1 ; ZINSMEISTER, Alan R1
[1] The Mayo Clinic, Rochester, Minnesota, United States
[2] University of Chicago, Chicago, Illinois, United States
[3] Long Island Clinical Research Associates, Greatneck, New York, United States
[4] Consultants for Clinical Research, Cincinnati, Ohio, United States
[5] Atlanta Gastroenterology Associates, Atlanta, Georgia, United States
[6] Tacoma Digestive Disease Center, Tacoma, Washington, United States - Source
Gastroenterology (New York, NY. 1943). 2001, Vol 121, Num 5, pp 1088-1094 ; ref : 33 ref
- CODEN
- GASTAB
- ISSN
- 0016-5085
- Domaine scientifique
- Gastroenterology
- Editeur
- Elsevier, New York, NY
- Pays de publication
- United States
- Type de document
- Article
- Langue
- English
- Mot clé (fr)
- Activité biologique Chimiothérapie Entérite Crohn Essai clinique Etanercept Etude double insu Homme Protéine fusion Randomisation Appareil digestif pathologie Intestin pathologie Maladie inflammatoire
- Mot clé (en)
- Biological activity Chemotherapy Crohn disease Clinical trial Etanercept Double blind study Human Fusion protein Randomization Digestive diseases Intestinal disease Inflammatory disease
- Mot clé (es)
- Actividad biológica Quimioterapia Enteritis Crohn Ensayo clínico Etanercept Estudio doble ciego Hombre Proteína fusionada Aleatorización Aparato digestivo patología Intestino patología Enfermedad inflamatoria
- Classification
- Pascal
- 002 Sciences biologiques et medicales / 002B Sciences medicales / 002B02 Pharmacologie. Traitements medicamenteux / 002B02H Appareil digestif
- Discipline
- Pharmacological treatments
- Provenance
- Inist-CNRS
- Base de données
- PASCAL
- Identifiant INIST
- 14098203
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Accès au Document
Installer sur votre navigateur
DOI
10.1053/gast.2001.28674 
https://dx.doi.org/10.1053/gast.2001.28674
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1053\/gast.2001.28674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Gastroenterology (New York, NY. 1943)\";s:9:\"\u0000*\u0000stitle\";s:32:\"Gastroenterology (N.Y. NY, 1943)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1088\";s:8:\"\u0000*\u0000epage\";s:4:\"1094\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0016-5085\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:18:\"HANAUER, Stephen B\";i:1;s:13:\"KATZ, Seymour\";i:2;s:14:\"SAFDI, Michael\";i:3;s:15:\"WOLF, Douglas G\";i:4;s:16:\"BAERG, Richard D\";i:5;s:19:\"TREMAINE, William J\";i:6;s:16:\"JOHNSON, Therese\";i:7;s:14:\"DIEHL, Nancy N\";i:8;s:19:\"ZINSMEISTER, Alan R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GASTAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1053\/gast.2001.28674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Gastroenterology (New York, NY. 1943)\";s:9:\"\u0000*\u0000stitle\";s:32:\"Gastroenterology (N.Y. NY, 1943)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1088\";s:8:\"\u0000*\u0000epage\";s:4:\"1094\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0016-5085\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:18:\"HANAUER, Stephen B\";i:1;s:13:\"KATZ, Seymour\";i:2;s:14:\"SAFDI, Michael\";i:3;s:15:\"WOLF, Douglas G\";i:4;s:16:\"BAERG, Richard D\";i:5;s:19:\"TREMAINE, William J\";i:6;s:16:\"JOHNSON, Therese\";i:7;s:14:\"DIEHL, Nancy N\";i:8;s:19:\"ZINSMEISTER, Alan R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GASTAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1053\/gast.2001.28674\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Accès par Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1053\/gast.2001.28674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Gastroenterology (New York, NY. 1943)\";s:9:\"\u0000*\u0000stitle\";s:32:\"Gastroenterology (N.Y. NY, 1943)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1088\";s:8:\"\u0000*\u0000epage\";s:4:\"1094\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0016-5085\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:18:\"HANAUER, Stephen B\";i:1;s:13:\"KATZ, Seymour\";i:2;s:14:\"SAFDI, Michael\";i:3;s:15:\"WOLF, Douglas G\";i:4;s:16:\"BAERG, Richard D\";i:5;s:19:\"TREMAINE, William J\";i:6;s:16:\"JOHNSON, Therese\";i:7;s:14:\"DIEHL, Nancy N\";i:8;s:19:\"ZINSMEISTER, Alan R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GASTAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Europe PubMed Central
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1053\/gast.2001.28674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Gastroenterology (New York, NY. 1943)\";s:9:\"\u0000*\u0000stitle\";s:32:\"Gastroenterology (N.Y. NY, 1943)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1088\";s:8:\"\u0000*\u0000epage\";s:4:\"1094\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0016-5085\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:18:\"HANAUER, Stephen B\";i:1;s:13:\"KATZ, Seymour\";i:2;s:14:\"SAFDI, Michael\";i:3;s:15:\"WOLF, Douglas G\";i:4;s:16:\"BAERG, Richard D\";i:5;s:19:\"TREMAINE, William J\";i:6;s:16:\"JOHNSON, Therese\";i:7;s:14:\"DIEHL, Nancy N\";i:8;s:19:\"ZINSMEISTER, Alan R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GASTAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par Base Search
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1053\/gast.2001.28674\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Gastroenterology (New York, NY. 1943)\";s:9:\"\u0000*\u0000stitle\";s:32:\"Gastroenterology (N.Y. NY, 1943)\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"121\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"1088\";s:8:\"\u0000*\u0000epage\";s:4:\"1094\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0016-5085\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SANDBORN\";s:10:\"\u0000*\u0000aufirst\";s:9:\"William J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:18:\"HANAUER, Stephen B\";i:1;s:13:\"KATZ, Seymour\";i:2;s:14:\"SAFDI, Michael\";i:3;s:15:\"WOLF, Douglas G\";i:4;s:16:\"BAERG, Richard D\";i:5;s:19:\"TREMAINE, William J\";i:6;s:16:\"JOHNSON, Therese\";i:7;s:14:\"DIEHL, Nancy N\";i:8;s:19:\"ZINSMEISTER, Alan R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GASTAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Etanercept for active Crohn's disease : A randomized, double-blind, placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Accès par arXiv
